Search company, investor...

Founded Year



Series B | Alive

Total Raised


Last Raised

$45M | 2 yrs ago

Mosaic Score
The Mosaic Score is an algorithm that measures the overall financial health and market potential of private companies.

+20 points in the past 30 days

About BioIntelliSense

BioIntelliSense is a company focused on continuous health monitoring and clinical intelligence in the healthcare sector. The company offers a comprehensive portfolio of continuous patient monitoring solutions, including wearable devices and advanced data services, that capture vital signs and physiological biometrics for both in-hospital and home use. These solutions primarily cater to the healthcare industry. It was founded in 2018 and is based in Golden, Colorado.

Headquarters Location

17301 W. Colfax Avenue Suite 152

Golden, Colorado, 80401,

United States

(888) 908-8804


ESPs containing BioIntelliSense

The ESP matrix leverages data and analyst insight to identify and rank leading companies in a given technology landscape.

Healthcare & Life Sciences / Monitoring, Imaging & Diagnostics Tech

The wearable vital sign monitoring market offers technology solutions that can monitor patients' vital signs continuously and wirelessly, both in hospital and remote settings. These devices track multiple vital signs such as heart rate, body temperature, and respiration rate without the need for traditional medical devices. The wearables are designed to be comfortable, lightweight, and easy to use…

BioIntelliSense named as Leader among 12 other companies, including Biofourmis, Withings, and PhysIQ.


Research containing BioIntelliSense

Get data-driven expert analysis from the CB Insights Intelligence Unit.

CB Insights Intelligence Analysts have mentioned BioIntelliSense in 4 CB Insights research briefs, most recently on Aug 15, 2023.

Expert Collections containing BioIntelliSense

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

BioIntelliSense is included in 5 Expert Collections, including Value-Based Care & Population Health.


Value-Based Care & Population Health

1,066 items

The VBC & Population Health collection includes companies that enable and deliver care models that address the health needs for defining populations along the continuum of care, including in the community setting, through participation, engagement, and targeted interventions.


Conference Exhibitors

5,302 items


Digital Health 150

300 items

The winners of the second annual CB Insights Digital Health 150.


Digital Health

10,585 items

The digital health collection includes vendors developing software, platforms, sensor & robotic hardware, health data infrastructure, and tech-enabled services in healthcare. The list excludes pureplay pharma/biopharma, sequencing instruments, gene editing, and assistive tech.



2,856 items

Companies developing, offering, or using electronic and telecommunication technologies to facilitate the delivery of health & wellness services from a distance. *Columns updated as regularly as possible; priority given to companies with the most and/or most recent funding.

BioIntelliSense Patents

BioIntelliSense has filed 15 patents.

The 3 most popular patent topics include:

  • computer buses
  • biometrics
  • computer connectors
patents chart

Application Date

Grant Date


Related Topics




Adhesives, Intermolecular forces, Mechanical engineering, Organic chemistry, Geopoliticians


Application Date


Grant Date



Related Topics

Adhesives, Intermolecular forces, Mechanical engineering, Organic chemistry, Geopoliticians



Latest BioIntelliSense News

UC Davis Health Launch Continuous Monitoring Program for Bone Marrow Transplant Patients

Nov 21, 2023

What You Should Know: BioIntelliSense , a continuous health monitoring and clinical intelligence company, and California-based UC Davis Health, announce the launch of a new in-hospital monitoring initiative for patients hospitalized for Bone Marrow Transplant and Hematology/Oncology services. The transformational program leverages the BioIntelliSense FDA-cleared BioButton® wearable devices, algorithmic-based data analytics, and clinical intelligence system to monitor for subtle changes in vital sign trends and signs of potential patient deterioration for actionable clinical decisions and proactive interventions. Revolutionising Patient Monitoring: BioIntelliSense at UC Davis Health The BioButton, a medical-grade device, effortlessly records up to 1,440 sets of vital sign measurements per patient daily to monitor medical-surgical patients for potential complications after procedures. Positioned on the upper left chest, the multi-parameter BioButton securely gathers heart rate, respiratory rate, skin temperature trends, and various physiologic biometrics. Detecting clinically meaningful changes in vital signs, it provides an intuitive display of patient data and algorithmic-based notifications within the comprehensive BioIntelliSense clinical intelligence solution. UC Davis Health, an acclaimed academic medical center, is at the forefront of digital transformation initiatives for equitable, accessible, and cost-effective patient care. Spearheaded by the UC Davis Health Digital CoLab, the BioIntelliSense project is driven by their dedication to identifying, evaluating, and implementing top-tier technologies and programs. “Our first priority is to provide the best care experience possible, which is even more critical when dealing with our most vulnerable patients, who are at risk for changes in condition,” said Christine Williams, interim chief nursing and patient care services officer at UC Davis Health. “With the BioButton device and timely insights, our clinical teams can explore new innovations and solutions for continuously monitoring a patient’s health status.”

BioIntelliSense Frequently Asked Questions (FAQ)

  • When was BioIntelliSense founded?

    BioIntelliSense was founded in 2018.

  • Where is BioIntelliSense's headquarters?

    BioIntelliSense's headquarters is located at 17301 W. Colfax Avenue, Golden.

  • What is BioIntelliSense's latest funding round?

    BioIntelliSense's latest funding round is Series B.

  • How much did BioIntelliSense raise?

    BioIntelliSense raised a total of $84.8M.

  • Who are the investors of BioIntelliSense?

    Investors of BioIntelliSense include 7wire Ventures, Fresenius Medical Care, Philips, CU Healthcare Innovation Fund, Jim Murren and 10 more.

  • Who are BioIntelliSense's competitors?

    Competitors of BioIntelliSense include BioBeat and 3 more.


Compare BioIntelliSense to Competitors

VitalConnect Logo

VitalConnect develops a wearable biosensor technology for wireless patient monitoring in both hospital and remote patient populations. It uses biomedical engineering, data analytics, chip design, and mobile and cloud software to create technology. Its products cater to hospital monitoring, post-discharge care, cardiac monitoring, and pharmaceutical solutions. The company was formerly known as Vigilo Networks. VitalConnect was founded in 2011 and is based in San Jose, California.

Donisi Health

Donisi Health is a MedTech company with a focus on aiding patients with Congestive Heart Failure (CHF) and other chronic cardiopulmonary diseases. The company offers FDA-cleared, contact-free technology that remotely detects signs of pulmonary congestion, supporting early detection of changes in lung fluid content and helping to prevent unnecessary rehospitalization. Donisi Health primarily serves the healthcare industry. It was founded in 2015 and is based in Tel Aviv, Israel.

Casana Logo

Casana develops patient monitoring devices. It offers Heart Seat that monitors blood oxygen level, blood pressure, heart rate, and more to help patients stay healthier at home. It was formerly known as Heart Health Intelligence. It was founded in 2018 and is based in Rochester, New York.


Dynocardia is a biomedical device development company focused on improving healthcare worldwide. The company's main product is a wearable and connected platform technology that provides accurate and continuous monitoring of blood pressure and other vital heart and lung functions. Dynocardia primarily serves markets such as hospitals, clinical practices, remote patient monitoring, consumer wellness, and disease prevention. It was founded in 2018 and is based in Cambridge, Massachusetts.

Biofourmis Logo

Biofourmis discovers, develops, and delivers clinically-validated, software-based therapeutics. The company produces Biovital, a personalized, artificial intelligence (AI) powered health analytics platform to predict clinical exacerbation. It was founded in 2015 and is based in Boston, Massachusetts.

Catapult Sports Logo
Catapult Sports

Catapult Sports is a company that focuses on sports technology and data analytics. The company offers solutions for athlete monitoring, video analysis, and recruiting, providing teams and organizations with the tools to enhance their performance and potential. Catapult Sports primarily serves the sports industry, working with teams across a variety of sports globally. It was founded in 2006 and is based in Prahran, Victoria.


CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.